VXUS vs VEA: returns, risk and drawdowns compared
Vanguard Total International Stock ETF against Vanguard FTSE Developed Markets ETF, over the same 6 years (July 2020 to November 2026) with dividends reinvested.
Data updated November 2026
VXUS
Vanguard Total International Stock ETF
10,000 became
19,603
- A year on average
- +11.1%
- Annual volatility
- 14.9%
- Deepest fall
- −27.8%
- Worst month
- −9.9%
VEA
Vanguard FTSE Developed Markets ETF
10,000 became
20,900
- A year on average
- +12.2%
- Annual volatility
- 15.9%
- Deepest fall
- −28.1%
- Worst month
- −9.9%
VEA came out ahead by 1.1 percentage points a year from July 2020 to November 2026. VEA swung more (15.9% against 14.9% a year). The correlation of monthly returns was 0.99: they moved almost in lockstep.
Growth of 10,000: VXUS vs VEA
Who was ahead, and when
The gap between the two over the previous three years, at each month-end. Above zero VXUS had returned more, below zero VEA. VXUS was ahead in 0% of the 42 three-year periods.
Annualised 3-year return of VXUS minus that of VEA, in percentage points a year.
Falls from the previous high
Month-end values. Deepest fall: VXUS −27.8%, VEA −28.1%.
All the figures
| VXUS | VEA | |
|---|---|---|
| Annual return (CAGR) | +11.1% | +12.2% |
| Total return | +96% | +109% |
| Annual volatility | 14.9% | 15.9% |
| Deepest fall (month-end) | −27.8% | −28.1% |
| Worst month | −9.9% | −9.9% |
| Best month | +13.0% | +14.3% |
| Positive months | 58% | 60% |
| Best year | 2025: +32.4% | 2025: +35.2% |
| Worst year | 2022: −16.1% | 2022: −15.3% |
| 1-year return | +11.1% | +14.3% |
| 5 years, a year | +7.3% | +8.5% |
| 10 years, a year | +9.0% | — |
| Trading currency | USD | USD |
First nine rows: the same 77 months for both funds. Trailing returns: to each fund’s last close.
Year by year
Full calendar years both funds were trading. The higher of the two each year is in bold.
Holding both: half VXUS, half VEA
| VXUS alone | VEA alone | 50/50 | |
|---|---|---|---|
| A year on average | +11.1% | +12.2% | +11.6% |
| Annual volatility | 14.9% | 15.9% | 15.3% |
| Deepest fall (month-end) | −27.8% | −28.1% | −27.9% |
| Worst month | −9.9% | −9.9% | −9.9% |
With a correlation of 0.99 the mix behaved almost like either fund alone: its volatility of 15.3% sits between the two. Rebalanced to 50/50 every month, before costs.
Questions
Which has returned more, VXUS or VEA?
From July 2020 to November 2026, VXUS returned +11.1% a year and VEA +12.2% a year, with dividends reinvested. Over rolling 3-year periods VXUS did better in 0% of cases. Past returns do not predict future returns.
Which is riskier, VXUS or VEA?
Over the same months annual volatility was 14.9% for VXUS and 15.9% for VEA; the deepest fall from a month-end high was 27.8% and 28.1%, and the worst single month −9.9% and −9.9%.
How correlated are VXUS and VEA?
The correlation of their monthly returns was 0.99: they moved almost in lockstep. Holding both adds little diversification compared with holding one.
What about holding both VXUS and VEA?
Half in each, rebalanced every month, returned +11.6% a year over the same period, with 15.3% annual volatility and a deepest month-end fall of 27.9%.
More comparisons
- VXUS — Vanguard Total International Stock ETFReturns, drawdowns and risk
- VEA — Vanguard FTSE Developed Markets ETFReturns, drawdowns and risk
- VXUS vs IEFA
- VXUS vs EFA
- VTI vs VXUS
- VEA vs IEFA
- VEA vs EFA
- VEA vs VWO
- VEA vs VGK
- Backtest a portfolio on past crisesRebalancing, costs and attribution
- Portfolio stress testing software comparedFeatures and prices side by side
How the figures are calculated
Total return in the fund’s trading currency, from end-of-day prices with dividends reinvested on the ex-date. The fund’s own ongoing charges are already reflected in its price; trading costs, taxes and currency conversion are not included. Past returns do not predict future returns.
The comparison uses only the months in which both funds have prices, so the figures cover the same period even when one fund is older.
Source: MarketStack end-of-day prices, total return with dividends reinvested. Figures are historical and descriptive; they are not forecasts and not investment advice. MEDGE Capital does not recommend buying or selling any instrument. Risk disclaimer.